Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: Biogen looking at M&A as answer to failed Alzheimer's drug aducanumab
If they'd be willing to part with at least $5 billion USD, then I'd say go for it....but somehow I don't think Shenzhen Hepalink would agree, even though 43% or so of it would be their's.
